Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Cynthia Lullo

Physician Assistant Des Plaines, IL Physician Assistant

NPI 1063063584 CMS profile 11136007

1 N Broadway St, Des Plaines, IL 60016

Open in the dashboard

General payments

$5,560

235 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cynthia Lullo of Des Plaines, IL is reported in the CMS Open Payments database as having received $5,560 across 235 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,231 41
2024 General $1,246 55
2023 General $886 42
2022 General $1,105 40
2021 General $1,092 57

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cynthia Lullo
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Cynthia Lullo were reported at $1,231. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Cynthia Lullo Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,092 $132 $37–$438 $132
2022 $1,105 $155 $48–$522 $149
2023 $886 $167 $52–$557 $160
2024 $1,246 $178 $55–$600 $164
2025 $1,231 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Corcept Therapeutics $1,120 50 payments
  2. Lilly USA, LLC $484 19 payments
  3. Bayer HealthCare Pharmaceuticals Inc. $389 14 payments
  4. Amgen Inc. $340 19 payments
  5. AbbVie, Inc. $271 10 payments
  6. GlaxoSmithKline, LLC. $263 16 payments
  7. Teva Pharmaceuticals USA, Inc. $222 3 payments
  8. Novo Nordisk Inc $222 3 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $209 11 payments
  10. Indivior Inc. $202 9 payments
  11. Other $1,837 81 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,560 235 payments
Products named General payments · program years 2021–2025
  1. Korlym $1,120 50 payments
  2. Kerendia $389 14 payments
  3. Otezla $321 18 payments
  4. Repatha $306 17 payments
  5. MOUNJARO $294 9 payments
  6. UZEDY $222 3 payments
  7. VRAYLAR $209 7 payments
  8. CAPLYTA $201 5 payments
  9. SUBLOCADE $189 8 payments
  10. NEXLETOL $171 13 payments
  11. Other $3,128 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

432

Median for Physician Assistant: 241

Drug cost

$60,838

Median for Physician Assistant: $4,110

Branded share of claims

11.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Trulicity Dulaglutide Brand 15 $31,185
Jardiance Empagliflozin Brand 16 $26,592
Atorvastatin Calcium Generic 104 $754
Amlodipine Besylate Generic 44 $357
Metformin Hcl Generic 44 $279
Lisinopril Generic 37 $227
Enalapril Maleate Generic 14 $192
Levothyroxine Sodium Generic 22 $174
Pioglitazone Hcl Generic 15 $164
Omeprazole Generic 14 $164

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 24 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Korlym
  • Corcept Therapeutics $154
$154 — —
UZEDY
  • Teva Pharmaceuticals USA, Inc. $122
$122 — —
GVOKE HYPOPEN
  • Xeris Pharmaceuticals, Inc. $115
$115 — —
SUBLOCADE
  • Indivior Inc. $94
$94 — —
VRAYLAR
  • AbbVie, Inc. $81
$81 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 24 in the dashboard with a free account

Records

235 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record